Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cristina Meazza & Sebastian Dorin Asaftei. (2021) State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma. Expert Opinion on Pharmacotherapy 22:15, pages 1995-2006.
Read now
Read now
Cristina Meazza, Roberto Luksch & Alessandro Luzzati. (2021) Managing axial bone sarcomas in childhood. Expert Review of Anticancer Therapy 21:7, pages 747-764.
Read now
Read now
Articles from other publishers (16)
Xianglin Hu, Tomohiro Fujiwara, Yangbai Sun, Wending Huang & Wangjun Yan. (2023) Does primary tumor resection improve survival for patients with sarcomas of pelvic bones, sacrum, and coccyx who have metastasis at diagnosis ?. European Spine Journal 32:12, pages 4362-4376.
Crossref
Crossref
Camille A. McAloney, Rawan Makkawi, Yogesh Budhathoki, Matthew V. Cannon, Emily M. Franz, Amy C. Gross, Maren Cam, Tatyana A. Vetter, Rebekka Duhen, Alexander E. Davies & Ryan D. Roberts. (2023) Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization. Cellular Oncology.
Crossref
Crossref
Roelof van Ewijk, Morgane Cleirec, Nikolas Herold, Marie-Cécile le Deley, Natasha van Eijkelenburg, Pascaline Boudou-Rouquette, Severine Risbourg, Sandra J. Strauss, Emanuela Palmerini, Kjetil Boye, Leo Kager, Stefanie Hecker-Nolting, Antonin Marchais & Nathalie Gaspar. (2023) A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: can we inform future trial design?. Cancer Treatment Reviews, pages 102625.
Crossref
Crossref
Wenchao Zhang, Lin Qi, Zhongyue Liu, Shasha He, Cheng‐zhi Wang, Ying Wu, Lianbin Han, Zhenxin Liu, Zheng Fu, Chao Tu & Zhihong Li. (2023) Integrated multiomic analysis and high‐throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy. MedComm 4:4.
Crossref
Crossref
Yang Lu, Ping LiYuandong Zhou & Jian Zhang. (2023) High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the
Progression of Osteosarcoma via the NF-κB Pathway in MG63 Cells. Current Cancer Drug Targets 23:6, pages 496-504.
Crossref
Crossref
Caihong Ye, Mengqi Wei, Huakun Huang, Yuping Wang, Lulu Zhang, Chunmei Yang, Yanran Huang & Jinyong Luo. (2022) Nitazoxanide inhibits osteosarcoma cells growth and metastasis by suppressing AKT/mTOR and Wnt/β-catenin signaling pathways. Biological Chemistry 403:10, pages 929-943.
Crossref
Crossref
Qian Chen, Junjie Wu, Kai ZhengMing XuZiwei Hou & Xiuchun Yu. (2022) Successful limb salvage in progressive proximal tibia osteosarcoma following denosumab chemotherapy: A case report. Medicine 101:30, pages e29812.
Crossref
Crossref
Maryam Farzaneh, Sajad Najafi, Omid Anbiyaee, Shirin Azizidoost & Seyed Esmaeil Khoshnam. (2022) LncRNA MALAT1-related signaling pathways in osteosarcoma. Clinical and Translational Oncology 25:1, pages 21-32.
Crossref
Crossref
Matteo Bruno Lodi. (2022) Recent Advances and Challenges of Magnetic Scaffolds for Tumor Hyperthermia and Tissue Engineering. Recent Advances and Challenges of Magnetic Scaffolds for Tumor Hyperthermia and Tissue Engineering.
Matteo B. Lodi, Nicola Curreli, Sonia Zappia, Luca Pilia, Maria Francesca Casula, Sergio Fiorito, Ilaria Catapano, Francesco Desogus, Teresa Pellegrino, Ilka Kriegel, Lorenzo Crocco, Giuseppe Mazzarella & Alessandro Fanti. (2022) Influence of Magnetic Scaffold Loading Patterns on Their Hyperthermic Potential Against Bone Tumors. IEEE Transactions on Biomedical Engineering 69:6, pages 2029-2040.
Crossref
Crossref
Matteo Bruno Lodi. (2022) Effects of the Inhomogeneous Loading of Magnetic Nanoparticles in Thermoseeds for Bone Tumors Hyperthermia. Effects of the Inhomogeneous Loading of Magnetic Nanoparticles in Thermoseeds for Bone Tumors Hyperthermia.
Duoli Xie, Zhuqian Wang, Jie Li, De-an Guo, Aiping Lu & Chao Liang. (2022) Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment. Frontiers in Oncology 12.
Crossref
Crossref
Krista A. Goulding, Benjamin K. Wilke, Hayley Cornwall Kiernan, Matthew T. Houdek & Courtney E. Sherman. (2022) Skeletal Sarcomas: Diagnosis, Treatment, and Follow-up from the Orthopedic Oncologist Perspective. Radiologic Clinics of North America 60:2, pages 193-203.
Crossref
Crossref
Bei Wang, Wen Xu, Chengyu Hu, Kai Liu, Jinlan Chen, Chong Guo & Chengfu Yuan. (2022) Critical roles of the lncRNA CASC11 in tumor progression and cancer metastasis: The biomarker and therapeutic target potential. Genes & Diseases 9:2, pages 325-333.
Crossref
Crossref
Shunichi Toki, Tetsuro Yoshimaru, Yosuke Matsushita, Hitoshi Aihara, Masaya Ono, Koichi Tsuneyama, Koichi Sairyo & Toyomasa Katagiri. (2021) The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3‐PHB2 complex formation. Cancer Science 112:10, pages 4208-4219.
Crossref
Crossref
Runsang Pan, Qiaoying Lu, Chong Ren, Hao Li, Fanqiang Zeng, Xiaobin Tian & Houping Chen. (2021) Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2. Aging 13:13, pages 17316-17327.
Crossref
Crossref